Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 20, 2025
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's diseaseStephen Salloway, Andrew Pain, Elly Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer modelEdwin C Pratt, David Bauer, Lukas M Carter, et al.
The Journal of Prevention of Alzheimer'S Disease|July 6, 2025
The effect of modified donanemab titration on amyloid-related imaging abnormalities with edema/effusions and amyloid reduction: 18-month results from TRAILBLAZER-ALZ 6Hong Wang, Emel Serap Monkul Nery, Paul Ardayfio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 11, 2026
Donanemab treatment effect by baseline tau burden and disease severity: Observations from the TRAILBLAZER-ALZ 2 trialLars L Raket, Ming Lu, Cynthia D Evans, et al.
EJNMMI Research|March 16, 2020
PET quantification of brain O-GlcNAcase with [<sup>18</sup>F]LSN3316612 in healthy human volunteersJae-Hoon Lee, Jeih-San Liow, Soumen Paul, et al.
Frontiers in Neuroscience|February 9, 2019
Study the Longitudinal <i>in vivo</i> and Cross-Sectional <i>ex vivo</i> Brain Volume Difference for Disease Progression and Treatment Effect on Mouse Model of Tauopathy Using Automated MRI Structural ParcellationDa Ma, Holly E Holmes, Manuel J Cardoso, et al.
Frontiers in Neuroscience|November 23, 2017
<i>In Vivo</i> Imaging of Tau Pathology Using Magnetic Resonance Imaging Textural AnalysisNiall Colgan, Balaji Ganeshan, Ian F Harrison, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2025
Modified titration of donanemab reduces ARIA risk and maintains amyloid reductionHong Wang, Emel Serap Monkul Nery, Paul Ardayfio, et al.
JAMA|July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical TrialJohn R Sims, Jennifer A Zimmer, Cynthia D Evans, et al.
Annals of Neurology|March 18, 2026
Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's DiseaseThomas F Tropea, Patricia Aldea Stevenson, Matthew Flitter, et al.
Pageof 4